Maxime Seligmann
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 18
- Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 22
- Immune Cell Function and Interaction 8
- Hematology top 1%
- Multiple Myeloma Research and Treatments 6
- Hepatology top 2%
-
- Lymphoma Diagnosis and Treatment 7
- Autoimmune Bullous Skin Diseases 6
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Glycosylation and Glycoproteins Research 10
- Co-authors
- Jean‐Claude BrouetF DanonJean‐Louis Preud'hommeJean‐Pierre ClauvelMichel KleinGeorges FlandrinEdith MihaescoD Hurez
- Cited by
- GeneticsImmunologyHematology
- Journals
- The American Journal of Medicine (5 papers)New England Journal of Medicine (5 papers)British Journal of Haematology (4 papers)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Maxime Seligmann
70 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 1.4k
- Immunology 1.8k
- Hematology 908
- Hepatology 457
- Pathology and Forensic Medicine 946
Countries citing papers authored by Maxime Seligmann
This map shows the geographic impact of Maxime Seligmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Seligmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Seligmann more than expected).
Fields of papers citing papers by Maxime Seligmann
This network shows the impact of papers produced by Maxime Seligmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Seligmann. The network helps show where Maxime Seligmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maxime Seligmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 46 | |
| 2 | 1994 | 14 | |
| 3 | 1993 | 35 | |
| 4 | 1990 | 3 | |
| 5 | 1989 | 31 | |
| 6 | 1989 | 33 | |
| 7 | 1988 | 33 | |
| 8 | 1987 | 67 | |
| 9 | 1987 | 79 | |
| 10 | 1986 | 57 | |
| 11 | 1979 | 3 | |
| 12 | 1979 | 7 | |
| 13 | 1978 | 3 | |
| 14 | Chronic lymphocytic leukaemia as an immunoproliferative disorder. | 1977 | 31 |
| 15 | 1975 | 3 | |
| 16 | 1974 | 1 | |
| 17 | 1972 | 119 | |
| 18 | 1969 | 13 | |
| 19 | 1968 | 62 | |
| 20 | 1967 | 58 |
About Maxime Seligmann
Maxime Seligmann is a scholar working on Genetics, Immunology, Hematology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 70 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (22 papers), Chronic Lymphocytic Leukemia Research (18 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (10 papers), Immune Cell Function and Interaction (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Autoimmune Bullous Skin Diseases (6 papers). The work is most often cited by research in Genetics (1.4k citations), Immunology (1.8k citations), Hematology (908 citations), Hepatology (457 citations) and Pathology and Forensic Medicine (946 citations). Maxime Seligmann has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Jean‐Claude Brouet, F Danon, Jean‐Louis Preud'homme, Jean‐Pierre Clauvel, Michel Klein, Georges Flandrin, Edith Mihaesco, D Hurez, Constantin Mihaesco and Roberto M. Arana. Their work appears in journals such as The American Journal of Medicine, New England Journal of Medicine, British Journal of Haematology, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.